New Medical Guidance on Cholesterol

Updated guidelines from the American College of Cardiology and the American Heart Association, supported by nine other medical groups, recommend that millions more adults consider starting cholesterol-lowering medications earlier to reduce their lifetime risk of heart attack and stroke. The guidance emphasizes earlier treatment, potentially starting in individuals as young as 30.

Key Recommendations

Statin therapy, in addition to lifestyle changes, is now recommended for adults aged 30 and older who meet specific criteria:

• An LDL cholesterol level of 160 milligrams per deciliter or higher.
• A strong family history of premature heart disease.
• A high 30-year risk of developing cardiovascular disease.

The new guidance marks a shift from solely assessing 10-year risk to also considering 30-year risk projections, which could significantly increase the number of individuals eligible for treatment. Dr. Jennifer Haythe noted that millions of Americans aged 30 to 44 could potentially qualify under these new criteria.

Benefits of Early Intervention

Studies indicate that a longer duration of reduced LDL cholesterol exposure leads to less plaque accumulation in arteries. Dr. Steven Nissen highlighted that starting treatment earlier may also allow for less intensive statin therapy, as the cumulative benefit over time can still achieve desired reductions in lifetime LDL cholesterol. Statins work by lowering LDL cholesterol, which contributes to arterial plaque buildup.

For adults aged 30 to 79 at borderline or intermediate risk who have started statins, the updated guideline suggests an LDL cholesterol target of less than 100 mg/dL. For those at the highest risk, the goal is less than 55 mg/dL.

Risk Assessment Tool

The updated guideline recommends using the American Heart Association’s Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) online calculator to evaluate an adult’s cardiovascular disease risk over 10 and 30 years. This tool is intended to facilitate discussions between clinicians and patients regarding preventive therapy options.

Patient Perspective

Gigi Gari Campos, an American Heart Association volunteer, shared her experience. She suffered a heart attack at age 34, despite knowing she had familial hypercholesterolemia. She expressed that earlier treatment could have potentially altered her health journey. Her doctors had previously hesitated to prescribe statins due to childbearing age considerations, a common concern as the FDA advises stopping statins during pregnancy. After her cardiac arrest, Campos resumed statin therapy and, through medication and lifestyle changes, significantly reduced her cholesterol levels.

Gigi Gari Campos emphasized the importance of achieving lower levels to prevent cardiac events, expressing that earlier treatment could have potentially altered her health journey.